More Than 60 Leading Health-Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing

February 7, 2019 – Leading health-care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare & Medicaid Services (CMS) to revise its interpretation of the National Coverage Determination (NCD) for Next-Generation Sequencing (NGS). In a letter to CMS Administrator Seema Verma, MD, 63 organizations expressed serious concerns that the overly … (leggi tutto)